- Nu.Q® Technology
Our technology detects characteristic epigenetic changes in nucleosomes that occur from the earliest stages of cancer, sepsis and other diseases.
-
- Our Tests
- Human Health
- Nu.Q® NETs
Nu.Q® NETs is a groundbreaking CE-marked diagnostic solution that clinicians can use to detect NETosis.
- Nu.Q® Discover
Buy our Nu.Q® Discover H3.1 Research Use Only Assay
- Animal Health
- Nu.Q® Vet Cancer Test
Nu.Q® Vet Cancer Test detects 76% of systemic cancers at 97% specificity.
Nick Plummer
Group General Counsel
Nick Plummer is Group General Counsel at Volition, with over 25 years’ experience as a corporate and commercial lawyer.
Nick is the Group General Counsel of Volition and joined the company in November 2021. He has over 25 years’ experience as a corporate and commercial lawyer, specializing in healthcare. Nick qualified with the international law firm, Ashurst, and has since worked in-house for companies such as Ark Therapeutics PLC and Patheon, which is part of Thermo Fisher Scientific.
Nick joined Volition from Novacyt, the Anglo-French AIM listed diagnostic company, where he managed the legal function.